times with PBS and wells were blocked with 5 % BSA for 2 h at 37 °C. Wells were washed 115 again and incubated with sera samples (in duplicate) diluted 1:100 in PBS/BSA for 2 h at 116 37 °C. Next, wells were incubated with HRP-conjugated anti-human IgG or IgM antibodies 117 (Sigma-Aldrich) diluted 1:500 in PBS/BSA for 90 min at 37 °C. The binding was revealed 118 with 0.5 mg/mL o-phenylenediamine dihydrochloride substrate (OPD) ( were coated with IgM from non-anemic and anemic P. vivax-infected patients (Fig. 1D) susceptibility of O nRBCs to in vitro phagocytosis (Fig. 1E ).
215
In relation to IgM (Fig. 1F ), no significant differences were detected among nRBCs from 216 different blood groups and either among antibodies from the different studied groups. These that also warrants further investigation.
279
In conclusion, the findings reported here give new information about the immune response 280 associated with clearance of nRBCs as well as its relationship with ABO blood groups in P. The authors would like to thank all patients and their families who contributed to the current 286 study. We are also grateful to health professionals and students from UFMT. 
